BCOP Updates 2026: Myth Busters: Hormone Replacement Therapy and Supplements in Breast and Gynecological Cancers
Hormone replacement therapy is a controversial topic in oncology due to the potential increased cancer risk, recurrence, and overall survival of patients – particularly in those with breast and gynecological malignancies. This session will explore the nuanced evidence of hormone replace therapy and the role in oncology, highlighting the delicate balance between symptom management and oncologic safety. This session will evaluate risks and benefits of HRT, including data supporting the impact on both cancer progression and quality of life. This session will also address the use of dietary supplements and non-hormonal pharmacologic agents with their potential interactions with cancer therapy. By the end of this session, you'll be equipped to critically appraise the evidence, make informed decisions even when data is limited, understand the landscape of supplement use, and effectively counsel your patients and colleagues.
BCOP Updates 2026: Myth Busters: Hormone Replacement Therapy and Supplements in Breast and Gynecological Cancers
Author: Miranda Benfield, PharmD, BCOP
Learning Objectives
- Analyze current evidence and clinical controversies surrounding hormone replacement therapy (HRT) in patients with breast and gynecologic cancers
- Discuss commonly used non-hormonal medications and supplements among patients with breast and gynecologic cancers and evaluate their potential risks, benefits, and drug interactions
- Evaluate the appropriateness of hormone replacement therapy (HRT) in a postmenopausal patient by integrating clinical trial evidence, patient-specific risk factors, and guideline recommendations to formulate an evidence-based treatment plan
- Develop individualized management strategies for menopausal symptoms in patients with breast or gynecologic cancer by comparing hormonal and non-hormonal options and incorporating patient-specific factors
Get it now!
Knowledge Course for Pharmacists
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.
All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.